Serum Opacity Factor Normalizes Erythrocyte Morphology in Scarb1<sup>-/-</sup> Mice in an HDL-Free Cholesterol-Dependent Way.

Overview

abstract

Compared to wild-type (WT) mice, high-density lipoprotein (HDL)-receptor-deficient (Scarb1^-/-) mice have higher plasma levels of free cholesterol (FC)-rich HDL and exhibit multiple pathologies associated with a high mol% FC in ovaries, platelets, and erythrocytes which are reversed by lowering HDL. Bacterial serum opacity factor (SOF) catalyzes the opacification of plasma by targeting and quantitatively converting HDL to neo HDL (HDL remnant), a cholesterol ester-rich microemulsion, and lipid-free APOA1. SOF delivery with an adeno-associated virus (AAV_SOF) constitutively lowers plasma HDL-FC and reverses female infertility in Scarb1^-/- mice in an HDL-dependent way. We tested whether AAV_SOF delivery to Scarb1^-/- mice will normalize erythrocyte morphology in an HDL-FC dependent way. We determined erythrocyte morphology and FC content (mol%) in three groups-WT, untreated Scarb1^-/- (control), and Scarb1^-/- mice receiving AAV_SOF-and correlated these with their respective HDL-mol% FC. Plasma-, HDL- and tissue-lipid compositions were also determined. Plasma- and HDL-mol% FC positively correlated across all groups. Among Scarb1^-/- mice, AAV_SOF treatment normalized reticulocyte number, erythrocyte morphology and erythrocyte-mol% FC. Erythrocyte-mol% FC positively correlated with HDL-mol% FC and with both the number of reticulocytes and abnormal erythrocytes. AAV_SOF treatment also reduced FC of extravascular tissues to a lesser extent. HDL-FC spontaneously transfers from plasma HDL to cell membranes. AAV_SOF treatment lowers erythrocyte-FC and normalizes erythrocyte morphology and lipid composition by reducing HDL-mol% FC.